Neoadjuvant Carboplatin in Triple Negative Breast Cancer

Clinical trial NCT02978495 · COMPLETED

Trial details

NCT number: NCT02978495
Sponsor: Barretos Cancer Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

BRCA1 Hereditary Breast and Ovarian Cancer Syndrome

Start date: 2017-05-17
Primary completion: 2019-12-02
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.